Literature DB >> 31884052

Impact of Stiffer Arteries on the Response to Antihypertensive Treatment: A Longitudinal Study of the SardiNIA Cohort.

Edward G Lakatta1, Danilo AlunniFegatelli2, Christopher H Morrell3, Edoardo Fiorillo4, Marco Orru4, Alessandro Delitala4, Michele Marongiu4, David Schlessinger5, Francesco Cucca6, Angelo Scuteri7.   

Abstract

OBJECTIVES: Carotid-femoral pulse wave velocity (PWV), an index of arterial stiffness and a proxy of arterial aging, has been reported to be an independent determinant of cardiovascular health. Whether the effects of antihypertensive treatment vary in the presence of accelerated arterial aging (stiffer artery, ie, PWV >10 m/s) has not been established. We tested this hypothesis in a longitudinal study in a large community-dwelling population.
DESIGN: Longitudinal population study with repeated measures. SETTING AND PARTICIPANTS: Study population consisted of a cohort of 6011 volunteers (2546 men and 3465 women, age range 14-101 years; 15,011 observations over a median follow-up of 6.8 years) participating in the SardiNIA Study. MEASURES: Repeated measures of PWV, blood pressure (BP), and metabolic risk factors and the antihypertensive medication trajectories of BP and PWV over time were assessed via mixed effects models.
RESULTS: Antihypertensive treatment significantly affected the trajectory of BP in both participants with (-0.47 ± 0.20 mmHg/y, P = .02) and participants without stiffer arteries (-0.47 ± 0.07 mmHg/y, P = .001). They also affected the trajectory of PWV in participants with stiffer artery, independent of the BP values. CONCLUSIONS AND IMPLICATIONS: Antihypertensive treatment is effective in reducing both BP and PWV in older individuals with stiffer arteries.
Copyright © 2019 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antihypertensive treatment; arterial stiffness; longitudinal cohort study; pulse wave velocity

Mesh:

Substances:

Year:  2019        PMID: 31884052     DOI: 10.1016/j.jamda.2019.11.014

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  2 in total

1.  Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension.

Authors:  Weiwei Zeng; Tanya T W Chu; Chung Shun Ho; Clara W S Lo; Alan S L Chan; Alice P S Kong; Brian Tomlinson; Sze Wa Chan
Journal:  Front Cardiovasc Med       Date:  2022-04-01

2.  Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study.

Authors:  Agne Laucyte-Cibulskiene; Chen-Huan Chen; John Cockroft; Pedro G Cunha; Maryam Kavousi; Aleksandras Laucevicius; Maria Lorenza Muiesan; Ernst R Rietzschel; Ligita Ryliskyte; Irina D Strazhesko; Charalambos Vlachopoulos; Jorge Cotter; Ekatherina N Dudinskaya; Nichola Gale; Fariba Ahmadizar; Francesco U S Mattace-Raso; Maggie Munnery; Pedro Oliveira; Anna Paini; Massimo Salvetti; Olga N Tkacheva; Edward G Lakatta; Peter M Nilsson; Angelo Scuteri
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.